NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-27 Cr | ₹-14 Cr | ₹-25 Cr | ₹-20 Cr | ₹-9.54 Cr |
What is the latest Cash Flow from Investing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2023 | ₹-27 Cr |
Mar2022 | ₹-14 Cr |
Mar2021 | ₹-25 Cr |
Mar2020 | ₹-20 Cr |
Mar2019 | ₹-9.54 Cr |
How is Cash Flow from Investing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-27 Cr | Negative | |
Mar2022 | ₹-14 Cr | Negative | |
Mar2021 | ₹-25 Cr | Negative | |
Mar2020 | ₹-20 Cr | Negative | |
Mar2019 | ₹-9.54 Cr | - |
Compare Cash Flow from Investing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,437.4 Cr | -12% | 8.5% | 53.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | -3.7% | -1.4% | 26% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -12% |
8.5% |
53.5% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses